ADIAL PHARMACEUTICALS CEO Cary Claiborne's 2022 pay jumps 118% to $1M
ADIAL PHARMACEUTICALS reports 2022 executive compensation
By ExecPay News
Published: September 29, 2023
ADIAL PHARMACEUTICALS reported fiscal year 2022 executive compensation information on September 29, 2023.
In 2022, four executives at ADIAL PHARMACEUTICALS received on average a compensation package of $635K, a 18% decrease compared to previous year.
Average pay of disclosed executives at ADIAL PHARMACEUTICALS
Cary J. Claiborne, Chief Executive Officer, received $1M in total, which increased by 118% compared to 2021. 59% of Claiborne's compensation, or $601K, was in option awards. Claiborne also received $357K in salary and $58K in other compensation.
William B. Stilley, Chief Executive Officer, received a compensation package of $592K, which decreased by 52% compared to previous year. 61% of the compensation package, or $364K, was in salary.
Bankole Johnson, Chief Medical Officer, earned $489K in 2022.
Joseph A. M. Truluck, Chief Financial Officer, received $443K in 2022, which decreases by 29% compared to 2021.
Related executives
You may also like
Source: SEC filing on September 29, 2023.